Interpace Biosciences, Inc.
IDXG· OTC
IDXGInterpace Biosciences, Inc.
Filed Mar 9, 2012 · 10-K · 69 days after period end · 0001054102-12-000008
derived · Computed from the longer spans the company filed.
| Metric | Q4 2011dderived from reported figures | Q4 2010dderived from reported figures |
|---|---|---|
| Revenue | $38.28M | — |
| Net Income | -$10.27M | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Interpace Biosciences, Inc. · CIK 1054102 · Engraved from SEC EDGAR
ended Dec 31, 2011 · filed Mar 9, 2012 · 69 d after period end
